Author: Lijiao Zeng; Jialu Li; Mingfeng Liao; Rui Hua; Pilai Huang; Mingxia Zhang; Youlong Zhang; Qinlang Shi; Zhaohua Xia; Xinzhong Ning; Dandan Liu; Jiu Mo; Ziyuan Zhou; Zigang Li; Yu Fu; Yuhui Liao; Jing Yuan; Lifei Wang; Qing He; Lei Liu; Kun Qiao
Title: Risk assessment of progression to severe conditions for patients with COVID-19 pneumonia: a single-center retrospective study Document date: 2020_3_30
ID: 8n3q30hy_15
Snippet: The severe group has a significantly lower number of platelet and lymphocytes but increased levels of coagulation function indicators such as fibrinogen, d-dimer and activated partial thromboplastin time. As for blood biochemistry, the biomarkers with a significantly increased level in severe group as compared to that of non-severe group include lactate dehydrogenase, myoglobin, aspartate transaminase, mitochondrial-aspartate transaminase, creati.....
Document: The severe group has a significantly lower number of platelet and lymphocytes but increased levels of coagulation function indicators such as fibrinogen, d-dimer and activated partial thromboplastin time. As for blood biochemistry, the biomarkers with a significantly increased level in severe group as compared to that of non-severe group include lactate dehydrogenase, myoglobin, aspartate transaminase, mitochondrial-aspartate transaminase, creatine kinase myocardial band, troponin I, N-terminal brain natriuretic peptide, γ -glutamyl transpeptidase and alpha-hydroxybutyrate dehydrogenase, while those with decreased levels include albumin and prealbumin. For the infection-related biomarkers, we observed a significant increase in C-reactive protein, interleukin-6, procalcitonin and erythrocyte sedimentation rate in severe group, all of which have a mean level beyond the upper bound of normal reference. We also observed an abnormal level of blood oxygen like PaO2/FiO2 ratio and kidney function indicators including All rights reserved. No reuse allowed without permission.
Search related documents:
Co phrase search for related documents- abnormal level and decrease level: 1
- abnormal level and increased level: 1, 2, 3, 4, 5, 6
- abnormal level and lactate dehydrogenase: 1, 2, 3, 4, 5
- abnormal level and lymphocyte platelet: 1, 2
- abnormal level and natriuretic peptide: 1, 2
- abnormal level and sedimentation rate: 1, 2
- abnormal level and severe group: 1, 2
- abnormal level and significantly increase: 1
- alpha hydroxybutyrate and lactate dehydrogenase: 1, 2
- alpha hydroxybutyrate and severe group: 1
- aspartate transaminase and blood biochemistry: 1, 2
- aspartate transaminase and blood oxygen: 1, 2, 3, 4, 5, 6
- aspartate transaminase and brain natriuretic peptide: 1, 2, 3, 4
- aspartate transaminase and increased level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- aspartate transaminase and kidney function: 1, 2, 3
- aspartate transaminase and lactate dehydrogenase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- aspartate transaminase and lymphocyte platelet: 1, 2, 3, 4, 5, 6, 7, 8
- aspartate transaminase and mean level: 1, 2
- aspartate transaminase and mitochondrial aspartate: 1
Co phrase search for related documents, hyperlinks ordered by date